| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7637cf2908ca898d7e16426b9ab7e1d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07a92e33ef03f850d03103ffd5cf1c30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e49b267524a0f999c0992baab4c7eb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a12318c35355ade0744ff3880eaa13b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 |
| filingDate |
2007-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85514aa1513730a038b896fe8dcc4438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45ac1f47336e8b65e06caa71286dba97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc0c170d728ecef4c3ae2fcc069443b4 |
| publicationDate |
2008-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008006511-A3 |
| titleOfInvention |
Use of fosfluridine tidoxil (ft) for the treatment of intraepithelial proliferative diseases |
| abstract |
The present invention is directed to the systemic administration of Fosfluridine Tidoxil, (5-fluorouridine)-5'-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt thereof, for the treatment of intraepithelial proliferative diseases such as actinic keratosis. The Fosfluridine Tidoxil can be systemically administered alone or in combination with topical treatment agents. |
| priorityDate |
2006-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |